AtaiBeckley (ATAI) Change in Account Payables (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Change in Account Payables of $6.0 million for Q1 2026, up 16447.22% year-over-year from N/an in Q1 2025, and up 16447.22% quarter-over-quarter from $36000.0 in Q1 2025.
Analysis
AtaiBeckley (ATAI) Change in Account Payables (2020 - 2026) Analysis & Trends
AtaiBeckley has reported Change in Account Payables for 6 years, with the latest figure at $1.8 million in Q3 2025.
- Quarterly Change in Account Payables rose 71.9% year-over-year to $1.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $442000.0 (up 163.41% YoY) and the FY2024 annual result came in at -$1.9 million, down 187.56% from the prior year.
- Change in Account Payables for Q1 2026 stood at $6.0 million, up from $36000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $6.0 million in Q1 2026, with the low at $36000.0 in Q1 2025.
- A 5-year average of $110894.7 and a median of -$22000.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2021 and 2025: Change in Account Payables plunged 1138.72% in 2021, then soared 3631.82% in 2025.
- Over 5 years, Change in Account Payables stood at $4.0 million in 2021, then tumbled by 115.06% to -$598000.0 in 2022, then sank by 60.2% to -$958000.0 in 2023, then slumped by 122.65% to -$2.1 million in 2024, then surged by 182.61% to $1.8 million in 2025.
- According to Business Quant data, Change in Account Payables over the past three periods registered $1.8 million, $777000.0, and $36000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | 1.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 788,000.00 |
| Mar 31, 2026 | 5.96 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 777,000.00 |
| Jun 30, 2025 | 777,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | -2.13 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | -742,000.00 |
| Dec 31, 2023 | -958,000.00 |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | -1.07 Mn |
| Mar 31, 2023 | 2.48 Mn |
| Dec 31, 2022 | -598,000.00 |
| Sep 30, 2022 | 155,000.00 |
| Jun 30, 2022 | -705,000.00 |
| Mar 31, 2022 | -1.89 Mn |
| Dec 31, 2021 | 3.97 Mn |